RE:RE:RE:RE:RE:RE:Baystreet Analysts : Share fair value price 46.70$ Investor2233 wrote: SNN is not risky in my mind. They have management that is experienced in runnning a successful winery.
Just not running a successful winery. The CEO sold his previous company ID Biomedical for 1.7 billion. You have to be pretty good to achieve that. I'm sure he will do the same with Sunniva.